41 Views | 29 Downloads
Anca Pantea Stoian, ancastoian@yahoo.com
The three authors have contributed equally to the present work. All authors have read and agreed to the published version of the manuscript.
The authors declare that this article has been written independently. APS is currently Vice President of Romanian National Diabetes Committee, and she has given lectures, received honoraria and research support, and participated in conferences, advisory boards, and clinical trials sponsored by many pharmaceutical companies including AstraZeneca, Boehringer Ingelheim, Medtronic, Eli Lilly, Merck, Novo Nordisk, Novartis, Roche Diagnostics, and Sanofi. MR is a full-time Professor of Internal Medicine at the University of Palermo, Italy, Editor in Chief of the International Journal of Molecular Sciences section Molecular Endocrinology and Metabolism, and currently Medical Director in Novo Nordisk Eastern Europe; he has given lectures, received honoraria and research support, and participated in conferences, advisory boards, and clinical trials sponsored by many pharmaceutical companies including Amgen, Astra Zeneca, Boehringer Ingelheim, Kowa, Eli Lilly, Meda, Mylan, Merck Sharp & Dohme, Novo Nordisk, Novartis, Roche Diagnostics, Sanofi, and Servier. None of the above-mentioned pharmaceutical companies had any role in this article, which has been written independently, without any financial or professional help, and reflects only the opinion of the authors, without any role of the industry.
This research received no external funding.
© 2021 by the authors.